Welcome

Deftly bridging from strategy to implementation, Meg uses her superior motivational and communication skills to build and lead top-tier global and domestic teams to achieve goals in Medical Affairs, External and Public Affairs, and Operations. She is a versatile leader and team player with extensive experience across domestic & international pharmaceutical, medical device and health technology markets.

Her consistent record of innovation and program development in cultivating successful academic, advocacy, government and corporate partnerships for companies in the U.S. and globally creates consensus and inspires healthcare transformative change.

As an expert in leading Medical Affairs and brand strategic teams, both in the US and globally, Flavia Dietrich is skilled at translating data into business opportunities and developing medical affairs strategies. She has extensive experience in interface with R&D, assessment of new opportunities, clinical development, and label development.   As a Global Medical Leader, she effectively manages diverse teams in all aspects of Medical Affairs: medical leads, medical publications, medical education, health outcomes, field medical liaisons, late phase research teams (US and Global).  

Flavia has scientific experience in various therapeutic areas, such as cardiovascular, thrombosis, hypertension, diabetes, respiratory/allergy, Central Nervous System (CNS), anti-infectives, pain, dry eye disease, immunology. She has been responsible for the medical launch strategy of various products, leading all phases of medical planning and execution (from global strategy to local sales training). 

She is a quick learner with a proven ability to transition from one therapeutic area to another and with working knowledge of Health Outcomes. Reputable and reliant, Flavia has led innovative projects in knowledge transfer, lifecycle management, and integration of real-world data into communications, advocacy, and education. Moreover, she has mentored and developed new talent from Medical Affairs and other functions, providing hands-on Global and Local strategic experience.

    Patrick is a Medical Affairs executive with over 30 years of experience within the pharmaceutical industry. His area of focus and expertise is Medical Affairs functional capabilities, where he helps organizations harmonize and transform those capabilities to enhance efficiencies, increase productivity, and create value. 

Patrick is currently the CEO of phactMI, a non-profit association representing medical information leadership of 30+ pharma companies. PhactMI is an industry-wide consortium that focuses on increasing awareness, credibility, and access to medical information. Prior to joining phactMI, Patrick worked at Bristol-Myers Squibb (BMS) where he held various leadership roles within the R&D organization. He led the US Clinical Site Monitoring organization in R&D operations and implemented the original Oncology and Immunoscience Field Medical teams in US Medical Affairs. Patrick also led the development and implementation of a global Field Medical capability in Europe, in support of several key launches. 

Patrick was a member of the Global Medical leadership team and provided executive sponsorship for several key initiatives and programs including developing new leaders through the BMS-Rutgers PharmD program; implementing new global systems and capabilities in support of a multichannel, customer-centric strategy; and helping to transform the organization to a specialty care biopharma model. 

Just before leaving BMS, Patrick led the globalization of the Medical Information capability by harmonizing customer engagement through the implementation of a global medical contact center, centralizing medical content creation and curation, and implementing a multichannel technology solution. 

Immediately following his retirement from BMS, Patrick was the interim head of the Global Medical Capabilities group within Global Medical Affairs at Amgen, where he led the implementation of this group as part of a global medical affairs transformation.

Patrick is a Physician Assistant and also has a Masters of Science degree in business administration and human resources management.

  Stacy is a Senior Medical Affairs Executive that has served clients that include global pharmaceutical corporations, medical associations, and medical communication companies. 

Stacey has extensive expertise in medical affairs for prescription and consumer products; Rx-to-OTC switch process; medical writing and editing clinical study protocols, clinical study reports and regulatory documents; publication planning, scientific manuscript preparation; scientific presentation development; presentation delivery (scientific topics); medical information management; strategic lifecycle planning and thought leader development  

  Paula Dietrich is an accomplished and experienced Assistant Professor with a demonstrated history of working in the higher education industry. She has a solid background in Molecular Biology, Genetics, Neurobiology, Developmental Biology, Mammalian Cell Culture, Histology, and Immunohistochemistry. 

Paula is a strong education professional with a bachelor's degree in Biology and a master's degree in Parasitology from University of Sāo Paulo (SP, Brazil) and Doctor of Philosophy (PhD) in Genetics and Development from Columbia University in the City of New York (NY, USA). She has over 25 years of experience in cellular and animal models of human neurodevelopmental and neurodegenerative disorders (in particular, Familial Dysautonomia, Parkinson's disease, and Huntington's disease). She has been a Review Editor in Neurogenomics (Frontiers in Neuroscience and Frontiers in Genetics), and an ad-hoc reviewer for various scientific journals for the past several years. Her list of accolades includes Author and Co-author of over 30 peer-reviewed original manuscripts in high-impact journals, including Nature, Neuron, J Clinical Investigation, Human Molecular Genetics, and J Neuroscience. As a passionate, thorough, and excellent writer, her work is featured in well-cited, first-author manuscripts, review articles, and book chapters in Movement Disorders. 

With a focus on market development, product launches, KOL engagement, and advocacy, Brad Harmon of Harmon Development Group have provided consulting services within the Healthcare Industry. Clients include, but are not limited to pharmaceutical companies, societies, foundations, and patient organizations who desire assistance with strategic development, program concepts, networking, and other activities within the healthcare sector.  

Having recently retired from Sanofi Pharmaceuticals, as the Head of Market Development for the U.S. Diabetes and Cardiovascular portfolio, Brad recognizes the gap organizations have in implementing a strategic approach to marketplace development. This translates across both the profit and non-profit sectors.  

During his tenure in the industry, he has a uniquely diverse background that has provided him with the insights to develop strategies that cross departmental boundaries and positively impact the marketplace and patient communities. Brad has been a core launch team member for more than 15 significant product launches for Sanofi and its legacy companies. In addition, he understands what is important to companies and can assist stakeholders in developing concepts and programming to forge partnerships with these groups. "Give customers a reason to do business with you."

 Keith is a charitable non-profit 501-(c)-3 executive with over thirty years of proven leadership and success, raising over $750 million in support of philanthropic efforts. His management skills include employee team building, training, retention, organizational assessment and accountability via budgeting and audit best practices and strategies. He is a motivated self-starter with a reputation for dedication, detailed management, transparency and a strong work ethic.

His philanthropic skills include strategy-driven principal and major gift fundraising, campaign planning, feasibility, and management, annual fund development and organizational assessment and growth. He is an excellent and energetic communicator with the ability to build strong working relationships with board members, staff, and organizational volunteers and supporters.